Next-gen Challenges

Back in the early days of next-gen sequencing, when the Solexa brand was still around, some serious challenges faced the field, MassGenomics' Dan Koboldt writes. Bioinformatics algorithms for capillary-based sequencing didn't scale, reads were shorter and error-prone, tools were expensive and hard to access, and few people had any experience with NGS.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Everybody's Got 'Em

Following the Curve

Sequencing to Go

A Deeper Bench

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.